Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

02 May 2020 Evaluate

Cadila Healthcare has informed that the company enclosed a Press Release dated May 2, 2020 titled ‘Zydus receives tentative approval from the USFDA for Empagliflozin and Metformin Hydrochloride Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..